Inivata

About:

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis.

Website: http://www.inivata.com/

Twitter/X: inivata

Top Investors: Cambridge Innovation Capital, Future Planet Capital, IP Group, Janus Henderson Investors, NeoGenomics

Description:

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.